Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 6, 2021; 9(19): 5046-5053
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5046
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5046
Clinical or pathological feature | n (%) |
< 40 yr | 34 (22.8) |
40-59 yr | 92 (61.8) |
≥ 60 yr | 23 (15.4) |
Stage 0 | 16 (10.7) |
Stage I | 46 (30.9) |
Stage II | 57 (38.3) |
Stage III | 27 (18.1) |
Stage IV | 3 (2.0) |
Luminal A | 31 (20.8) |
Luminal B (HER2 negative) | 54 (36.2) |
Luminal B (HER2 positive) | 39 (26.2) |
HER2 over expression type | 11 (7.4) |
Three negative type | 14 (9.4) |
< 40 yr | 40-59 yr | ≥ 60 yr | χ2 | P value | |
Left | 14 (41.2) | 50 (54.3) | 9 (39.1) | 4.246 | 0.374 |
Right | 20 (58.8) | 40 (43.5) | 13 (56.5) | ||
Bilateral | 0 (0.0) | 2(2.2) | 1 (4.3) | ||
Carcinoma in situ | 4 (11.8) | 16 (17.4) | 1 (4.3) | 2.783 | 0.249 |
Invasive carcinoma | 30 (88.2) | 76 (82.6) | 22 (95.7) | ||
Tis | 2 (5.9) | 14 (15.2) | 0 (0.0) | 15.469 | 0.051 |
T1 | 16 (47.1) | 31 (33.7) | 10 (43.5) | ||
T2 | 12 (35.3) | 38 (41.3) | 9 (39.1) | ||
T3 | 4 (11.8) | 7 (7.6) | 1 (4.3) | ||
T4 | 0 (0.0) | 2 (2.2) | 3 (13.0) | ||
N0 | 17 (50.0) | 57 (62.0) | 10 (43.5) | 6.486 | 0.371 |
N1 | 11 (32.4) | 19 (20.7) | 8 (34.8) | ||
N2 | 5 (14.7) | 8 (8.7) | 2 (8.7) | ||
N3 | 1 (2.9) | 8 (8.7) | 3 (13.0) | ||
M0 | 34 (100) | 9 1(98.9) | 21 (91.3) | 6.304 | 0.043 |
M1 | 0 (0.0) | 1 (1.1) | 2 (8.7) | ||
Luminal A | 7 (20.6) | 16 (17.4) | 8 (34.8) | 6.154 | 0.63 |
Luminal B(HER2 negative) | 13 (38.2) | 32 (34.8) | 9 (39.1) | ||
Luminal B (HER2 positive) | 8 (23.5) | 28 (30.4) | 3 (13.0) | ||
HER2 over expression type | 3 (8.8) | 6 (6.5) | 2 (8.7) | ||
Three negative type | 3 (8.8) | 10 (10.9) | 1 (4.3) |
Variable | B | Standard error | Waldorf | P value | Exp (B) | 95%CI of Exp (B) | |
Lower limit | Upper limit | ||||||
< 40 yr | 14.059 | 0.001 | |||||
40-59 yr | 0.603 | 0.277 | 4.741 | 0.029 | 1.828 | 1.062 | 3.148 |
≥ 60 yr | 2.059 | 0.568 | 13.128 | < 0.001 | 7.842 | 2.574 | 23.892 |
Age at menarche (≤ 14 yr, > 14 yr) | 0.965 | 0.261 | 13.633 | < 0.001 | 2.626 | 1.573 | 4.384 |
Age at first birth | 0.083 | 0.038 | 4.84 | 0.028 | 1.086 | 1.009 | 1.17 |
Number of births | 0.266 | 0.176 | 2.291 | 0.13 | 1.305 | 0.924 | 1.843 |
Number of miscarriages | -0.207 | 0.112 | 3.414 | 0.065 | 0.813 | 0.652 | 1.013 |
Breastfeeding (mo) | -0.009 | 0.011 | 0.665 | 0.415 | 0.991 | 0.97 | 1.013 |
History of family malignant tumors | 0.346 | 0.311 | 1.238 | 0.266 | 1.413 | 0.768 | 2.599 |
History of benign breast surgery | -1.355 | 0.489 | 7.664 | 0.006 | 0.258 | 0.099 | 0.673 |
Gynecological diseases | -0.357 | 0.299 | 1.42 | 0.233 | 0.7 | 0.389 | 1.258 |
Thyroid disease | -0.156 | 0.305 | 0.261 | 0.609 | 0.856 | 0.471 | 1.555 |
- Citation: Lei YY, Bai S, Chen QQ, Luo XJ, Li DM. Clinical and pathological features and risk factors for primary breast cancer patients. World J Clin Cases 2021; 9(19): 5046-5053
- URL: https://www.wjgnet.com/2307-8960/full/v9/i19/5046.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i19.5046